Co-Authors
This is a "connection" page, showing publications co-authored by Ali Al-Gareeb and Gaber Batiha.
Connection Strength
2.490
-
Covid-19 and development of heart failure: mystery and truth. Naunyn Schmiedebergs Arch Pharmacol. 2021 10; 394(10):2013-2021.
Score: 0.241
-
Impact of Sitagliptin in Non-Diabetic Covid-19 Patients. Curr Mol Pharmacol. 2021 Sep 01.
Score: 0.241
-
Levamisole Therapy in COVID-19. Viral Immunol. 2021 12; 34(10):722-725.
Score: 0.240
-
The potential role of neopterin in Covid-19: a new perspective. Mol Cell Biochem. 2021 Nov; 476(11):4161-4166.
Score: 0.240
-
The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections. Life (Basel). 2021 Jul 23; 11(8).
Score: 0.239
-
COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus. Front Cardiovasc Med. 2021; 8:644095.
Score: 0.237
-
The Looming Effects of Estrogen in Covid-19: A Rocky Rollout. Front Nutr. 2021; 8:649128.
Score: 0.234
-
COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin. Front Med (Lausanne). 2021; 8:644295.
Score: 0.233
-
Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances. Front Cardiovasc Med. 2021; 8:642181.
Score: 0.232
-
Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity. Eur J Pharmacol. 2021 Aug 05; 904:174196.
Score: 0.118
-
Pleiotropic Effects of Tetracyclines in the Management of COVID-19: Emerging Perspectives. Front Pharmacol. 2021; 12:642822.
Score: 0.118
-
Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects. Pulm Pharmacol Ther. 2021 04; 67:102008.
Score: 0.117